In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens.
The minimal inhibitory concentrations (MIC) of five tetracyclines and ten other antimicrobial agents were determined for four porcine bacterial respiratory tract pathogens by the agar dilution method. For the following oxytetracycline-susceptible strains, the MIC50 ranges of the tetracyclines were: P. multocida (n = 17) 0.25-0.5 micrograms/ml; B. bronchiseptica (n = 20) 0.25-1.0 micrograms/ml; H. pleuropneumoniae (n = 20) 0.25-0.5 micrograms/ml; S. suis Type 2 (n = 20) 0.06-0.25 micrograms/ml. For 19 oxytetracycline-resistant P. multocida strains the MIC50 of the tetracyclines varied from 64 micrograms/ml for oxytetracycline to 0.5 micrograms/ml for minocycline. Strikingly, minocycline showed no cross-resistance with oxytetracycline, tetracycline, chlortetracycline and doxycycline in P. multocida and in H. pleuropneumoniae. Moreover, in susceptible strains minocycline showed the highest in vitro activity followed by doxycycline. Low MIC50 values were observed for chloramphenicol, ampicillin, flumequine, ofloxacin and ciprofloxacin against P. multocida and H. pleuropneumoniae. B. bronchiseptica was moderately susceptible or resistant to these compounds. As expected tiamulin, lincomycin, tylosin and spiramycin were not active against H. pleuropneumoniae. Except for flumequine, the MIC50 values of nine antimicrobial agents were low for S. suis Type 2. Six strains of this species showed resistance to the macrolides and lincomycin.
Pijpers
A
A
Department of Herd Health, Faculty of Veterinary Medicine, State University of Utrecht, The Netherlands.
Van Klingeren
B
B
Schoevers
E J
EJ
Verheijden
J H
JH
Van Miert
A S
AS
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001884:Bordetella / Q000187:drug effects; D002751:Chlortetracycline / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D006190:Haemophilus / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology; D010325:Pasteurella / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000382:microbiology*; D013291:Streptococcus / Q000187:drug effects; D013552:Swine; D013553:Swine Diseases / Q000382:microbiology*; D013752:Tetracycline / Q000494:pharmacology; D013754:Tetracyclines / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D013754:Tetracyclines; D013752:Tetracycline; D008911:Minocycline; D004318:Doxycycline; D002751:Chlortetracycline; D010118:Oxytetracycline